Modulatory Effects of a Nutraceutical Supplement on Saos-2 Cells Reveal Its Phlebotonic Activity

ABSTRACT Objective: Herbal extract compositions are largely used to manage vein diseases. We prepared a new composition of herbs, named FLEBO OK™, that, when administered as a nutraceutical to patients affected by peripheral vascular diseases, was able to improve their health conditions. We analyzed the effects of this nutraceutical composition on in vitro cultured cells with the aim to obtain information about its mechanisms of action. Methods: A culture of human osteoblast cell line Saos-2 was stimulated with tumor necrosis factor (TNF)-α or interleukin (IL)-1β to induce the expression of some chemokines and matrix metalloproteases (MMPs). This cell culture was then exposed to the prepared composition and the amount of expression of the genes coding for the monocyte chemotactic protein (MCP)-1, IL-8, IL-1β, MMP-2, MMP-3, MMP-9 proteins was measured by real-time polymerase chain reaction (RT-PCR). The experiments were repeated exposing the cells to the same amount of the well-known micronized purified flavonoid fraction. Moreover, we describe the effects of the administration of nutraceutical composition to 20 patients affected by peripheral vascular diseases and 20 healthy individuals. Results: The RT-PCR analyses showed that the new composition induces the expression of MMP-3 and MMP-9 and downregulates MMP-2 in cell cultures stimulated with IL-1β, whereas it induces the expression of IL-8 and represses the expression of IL-1β and MCP-1 in cell cultures stimulated with TNF-α. The induction of the expression of MMP-3 and the downregulation of MCP-1 might result in an antiplatelet activity that was not observed for the micronized purified flavonoid fraction. Interviewed patients reported an improvement in their conditions after 1 month of FLEBO OK treatment. Conclusion: These findings could provide a hypothesis for the high efficiency of the identified nutraceutical composition to management of peripheral vascular diseases.

[1]  S. Ammendola,et al.  A Nutraceutical Composition Decreases CPK Levels in Saos-2 Cells and in Patients with Elevated Serum Levels of This Enzyme , 2016, Journal of the American College of Nutrition.

[2]  Xiangjia Zhu,et al.  Molecular Inflammation in the Contralateral Eye After Cataract Surgery in the First Eye. , 2015, Investigative ophthalmology & visual science.

[3]  F. Haidari,et al.  Hesperidin Supplementation Modulates Inflammatory Responses Following Myocardial Infarction , 2015, Journal of the American College of Nutrition.

[4]  J. Granjeiro,et al.  Bone tissue remodeling and development: focus on matrix metalloproteinase functions. , 2014, Archives of biochemistry and biophysics.

[5]  Feng Yang,et al.  Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling , 2013, Mediators of inflammation.

[6]  Yeon-Ah Lee,et al.  The role of adiponectin in the production of IL-6, IL-8, VEGF and MMPs in human endothelial cells and osteoblasts: implications for arthritic joints , 2013, Experimental & Molecular Medicine.

[7]  Jinho Lee,et al.  Effect of Rosemarinus officinalis L. on MMP-9, MCP-1 levels, and cell migration in RAW 264.7 and smooth muscle cells. , 2012, Journal of medicinal food.

[8]  H. Kwon,et al.  Matrix Metalloproteinase 9 (MMP-9)-dependent Processing of βig-h3 Protein Regulates Cell Migration, Invasion, and Adhesion* , 2012, The Journal of Biological Chemistry.

[9]  J. Teruya,et al.  Complications of anticoagulation. , 2012, Disease-a-month : DM.

[10]  M. Salai,et al.  The Effects of Direct Factor Xa Inhibitor (Rivaroxaban) on the Human Osteoblastic Cell Line SaOS2 , 2012, Connective tissue research.

[11]  Annelie Pichert,et al.  Functional aspects of the interaction between interleukin-8 and sulfated glycosaminoglycans , 2012, Biomatter.

[12]  B. Fingleton,et al.  An Osteoblast-Derived Proteinase Controls Tumor Cell Survival via TGF-beta Activation in the Bone Microenvironment , 2012, PloS one.

[13]  J. Raffetto,et al.  Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins. , 2011, Journal of vascular surgery.

[14]  H. Roach,et al.  Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. , 2011, European cells & materials.

[15]  G. Ramakrishnan,et al.  Modulatory effect of hesperidin on benzo(a)pyrene induced experimental lung carcinogenesis with reference to COX-2, MMP-2 and MMP-9. , 2010, European journal of pharmacology.

[16]  P. Gresele,et al.  Matrix metalloproteinases and peripheral arterial disease , 2010, Internal and emergency medicine.

[17]  Julie S. Jurenka.  Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. , 2009, Alternative medicine review : a journal of clinical therapeutic.

[18]  G. Jenkins.  The role of proteases in transforming growth factor-beta activation. , 2008, The international journal of biochemistry & cell biology.

[19]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[20]  C. Cicione,et al.  Glucosamine and its N-acetyl-phenylalanine derivative prevent TNF-alpha-induced transcriptional activation in human chondrocytes. , 2007, Clinical and experimental rheumatology.

[21]  C. Cicione,et al.  Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytes , 2007, Arthritis research & therapy.

[22]  T. Sasaoka,et al.  Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells. , 2007, European journal of pharmacology.

[23]  A. Spolarich,et al.  An examination of the bleeding complications associated with herbal supplements, antiplatelet and anticoagulant medications. , 2007, Journal of dental hygiene : JDH.

[24]  V. Keshamouni,et al.  Human α1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by α1β1 integrin. , 2020, The Journal of clinical investigation.

[25]  S. Milz,et al.  Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. , 2004, Anticancer research.

[26]  K. Egashira.  Molecular Mechanisms Mediating Inflammation in Vascular Disease: Special Reference to Monocyte Chemoattractant Protein-1 , 2003, Hypertension.

[27]  P. Wolna,et al.  Efficacy and Safety of a Butcher’s Broom Preparation (Ruscus aculeatus L. Extract) Compared to Placebo in Patients Suffering from Chronic Venous Insufficiency , 2002, Arzneimittelforschung.

[28]  B. Lal,et al.  Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. , 2001, Journal of vascular surgery.

[29]  B. Olsen,et al.  The role of collagen-derived proteolytic fragments in angiogenesis. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[30]  T. Shono,et al.  Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis , 1997, Molecular and cellular biology.

[31]  Y. Itoh,et al.  Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond. , 1996, Biochemistry.

[32]  Michael E. Hall,et al.  Using plasma matrix metalloproteinase-9 and monocyte chemoattractant protein-1 to predict future cardiovascular events in subjects with carotid atherosclerosis. , 2014, Atherosclerosis.

[33]  A. Ramelet.  Management of chronic venous disease: the example of Daflon 500 mg , 2009 .

[34]  Kirienko Ai,et al.  Stripping of the great saphenous vein under micronized purified flavonoid fraction (MPFF) protection (results of the Russian multicenter controlled trial DEFANCE) , 2008 .

[35]  V. Keshamouni,et al.  Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. , 2005, The Journal of clinical investigation.

[36]  A. Takeshita,et al.  Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention. , 2003, Journal of pharmacological sciences.